IRIS
BELLISAI, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.819
EU - Europa 4.086
AS - Asia 2.366
SA - Sud America 354
AF - Africa 117
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 3
AN - Antartide 1
Totale 12.756
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.730
RU - Federazione Russa 930
SG - Singapore 867
CN - Cina 739
GB - Regno Unito 684
IE - Irlanda 533
IT - Italia 496
SE - Svezia 349
BR - Brasile 304
DE - Germania 287
UA - Ucraina 264
FR - Francia 235
VN - Vietnam 210
HK - Hong Kong 175
FI - Finlandia 165
KR - Corea 98
IN - India 70
CA - Canada 54
ZA - Sudafrica 52
BD - Bangladesh 48
ES - Italia 36
IQ - Iraq 25
CI - Costa d'Avorio 20
JP - Giappone 19
AR - Argentina 17
PL - Polonia 17
MX - Messico 16
NL - Olanda 15
TR - Turchia 15
AT - Austria 14
BE - Belgio 14
CZ - Repubblica Ceca 13
PK - Pakistan 13
MA - Marocco 12
IR - Iran 11
NG - Nigeria 11
EC - Ecuador 10
UZ - Uzbekistan 10
AU - Australia 8
SA - Arabia Saudita 8
AE - Emirati Arabi Uniti 6
ID - Indonesia 6
IL - Israele 6
LT - Lituania 6
NP - Nepal 6
PH - Filippine 6
TN - Tunisia 6
DO - Repubblica Dominicana 5
EG - Egitto 5
JO - Giordania 5
KE - Kenya 5
KG - Kirghizistan 5
UY - Uruguay 5
BG - Bulgaria 4
CO - Colombia 4
GR - Grecia 4
JM - Giamaica 4
PY - Paraguay 4
VE - Venezuela 4
HR - Croazia 3
AM - Armenia 2
BO - Bolivia 2
BS - Bahamas 2
BY - Bielorussia 2
CH - Svizzera 2
CL - Cile 2
CU - Cuba 2
DZ - Algeria 2
EE - Estonia 2
EU - Europa 2
GT - Guatemala 2
HU - Ungheria 2
IM - Isola di Man 2
KZ - Kazakistan 2
LB - Libano 2
OM - Oman 2
RO - Romania 2
TW - Taiwan 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AO - Angola 1
AQ - Antartide 1
AZ - Azerbaigian 1
BH - Bahrain 1
CR - Costa Rica 1
DK - Danimarca 1
ET - Etiopia 1
GY - Guiana 1
HN - Honduras 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MY - Malesia 1
NC - Nuova Caledonia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
QA - Qatar 1
Totale 12.751
Salva come PNG Salva come JPEG
Città #
Dallas 924
Menlo Park 785
Singapore 607
Southend 588
Dublin 523
Ashburn 402
Fairfield 355
Chandler 287
San Jose 266
Santa Clara 263
Moscow 257
Jacksonville 203
Beijing 194
Woodbridge 172
Hong Kong 170
Milan 151
Wilmington 137
Houston 132
Seattle 131
Hefei 122
Ann Arbor 116
Cambridge 109
Princeton 97
Seoul 97
New York 91
Helsinki 90
Los Angeles 89
The Dalles 88
Munich 81
Nanjing 72
Ho Chi Minh City 71
Rome 71
Council Bluffs 67
Siena 60
Lauterbourg 55
Hanoi 48
Johannesburg 44
San Mateo 37
Boardman 36
Dearborn 35
Buffalo 32
São Paulo 30
Turku 26
Nanchang 25
San Diego 24
Orem 23
Shanghai 22
Abidjan 20
Chicago 20
Frankfurt am Main 20
London 20
Columbus 18
Tokyo 18
Düsseldorf 17
Málaga 17
Chennai 16
Denver 16
Florence 16
Montreal 16
Stockholm 16
Warsaw 16
Bengaluru 15
Brooklyn 15
Shenyang 15
Brussels 14
Dong Ket 14
San Francisco 14
Toronto 14
Venezia 14
Washington 14
Atlanta 13
Figino 13
Hebei 13
Changsha 12
Jinan 12
Redondo Beach 12
Rio de Janeiro 12
Tianjin 12
Vienna 12
Abuja 11
Guangzhou 11
Baghdad 10
Da Nang 10
Mumbai 9
Ningbo 9
Nuremberg 9
Phoenix 9
Tashkent 9
Belo Horizonte 8
Brno 8
Haiphong 8
Portsmouth 8
Fremont 7
Guayaquil 7
Kunming 7
Lappeenranta 7
Mexico City 7
Amsterdam 6
Jiaxing 6
Manchester 6
Totale 8.963
Salva come PNG Salva come JPEG
Nome #
Eosinophilia-associated muscle disorders:an immunohistological study with tissue localisation of major basic protein in distinct clinicopathological forms 362
Absence of anti-cyclic citrullinated peptide antibodies in erosive osteoarthritis: further serological evidence of the disease as a subset of osteoarthritis 313
POS0871 diagnostic accuracy og power doppler ultrasonography for the diagnosis of idiopathic inflammmatory myopathies 299
High levels of maternal serum IL-17 and activin A in pregnant women affected by systemic lupus erythematosus 299
Low serum level of COMP, a cartilage turnover marker, predicts rapid and high ACR70 response to adalimumab therapy in rheumatoid arthritis 297
Anti-cofactor autoantibodies in systemic lupus erythematosus: prevalence, clinical and HLA class II associations 297
Safety of cyclosporin A in HCV-infected patients: experience with cyclosporin A in patients affected by rheumatological disorders and concomitant HCV infection 294
Accuracy of power Doppler ultrasonography in the diagnosis and monitoring of idiopathic inflammatory myopathies 291
Validation of a diagnostic score for the diagnosis of autoinflammatory diseases in adults 291
Switch from infliximab to infliximab biosimilar: efficacy and safety in a cohort of patients with different rheumatic diseases: Response to: Nikiphorou E, Kautiainen H, Hannonen P, et al. Clinical effectiveness of CT-P13 (Infliximab biosimilar) used as a switch from Remicade (infliximab) in patients with established rheumatic disease. Report of clinical experience based on prospective observational data. Expert Opin Biol Ther. 2015;15:1677–1683 286
Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro/SSA and connective tissue disease 275
Bone status of children born from mothers with autoimmune diseases treated during pregnancy with prednisone and/or low molecular weight heparin 272
Anti-ganglioside antibodies in a large cohort of European patients with systemic lupus erythematosus: Clinical, serological, and HLA class II gene associations 268
Cyclosporine A for the treatment of autoimmune disorders in HCV infected patients 267
Anticardiolipin and antibeta2GPI antibodies In a large series of european patients with systemic lupus erythematosus: prevalence and clinical association 260
Chromosomal abnormalities in peripheral lymphocytes from idiopathic Raynaud's phenomenon patients 253
Safety and efficacy of etanercept in children with juvenile-onset Behcets disease 252
Association of extrahepatic manifestations with HLA class II alleles and with virus genotype in HCV infected patients 251
Cartilage oligomeric matrix protein level in rheumatic diseases: potential use as a marker for measuring articular cartilage damage and/or the therapeutic efficacy of treatments 248
Chromosome aberrations in Raynaud's phenomenon 248
Viral genotype and HLA class II alleles influence on extra-hepatic manifestations of chronic HCV infection 247
A novel grey scale and Power Doppler ultrasonographic score for idiopathic inflammatory myopathies: Siena Myositis Ultrasound Grading Scale 241
Relationship between serum comp levels and serological markers of disease activity in rheumatoid arthritis patients treated with anti-tnf drugs. A study of the best way to manage indicators of response to therapy 231
COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs 229
Primary anti-phospholipid syndrome: any role for serum complement levels in predicting pregnancy complications? 222
Detection of anti-IFI16 antibodies by ELISA: clinical and serological associations in systemic sclerosis 218
Exploring the crosstalk between hydrostatic pressure and adipokines: an in vitro study on human osteoarthritic chondrocytes 216
Prevalence of anti-Histone antibodies, their clinical significante and correlation with other autoantibodies in a color of italian scleroderma patients 212
Anterior chest wall non-traumatic diseases: A road map for the radiologist 208
Peripheral Macrovascular Involvement in Systemic Sclerosis: A Cohort Study by Color and Spectral Doppler Ultrasonography 207
Pregnancy in Wegener's granulomatosis: successful treatment with intravenous immunoglobulin 205
Infliximab treatment in a patient with systemic sclerosis associated with lung fibrosis and pulmonary hypertension 202
Efficacy of baricitinib in treating rheumatoid arthritis: Modulatory effects on fibrotic and inflammatory biomarkers in a real-life setting 201
Anti-Cytosolic 5′-Nucleotidase 1A in the Diagnosis of Patients with Suspected Idiopathic Inflammatory Myopathies: An Italian Real-Life, Single-Centre Retrospective Study 199
HCV e malattie autoimmuni 197
HLA-DPB1 alleles association of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus 188
Treatment strategies for apatient with rheumatoid arthritis and hepatitis C 186
Bone-sparing effects of rituximab and body composition analysis in a cohort of postmenopausal women affected by rheumatoid arthritis – retrospective study 184
Coexistence of the antiphospholipid syndrome and abdominal aortic aneurysm 179
Clinical, laboratory and ultrasonographic findings at baseline predict long-term outcome of polymyalgia rheumatica: a multicentric retrospective study : Polymyalgia rheumatica predicted by ultrasonographic findings polymyalgia rheumatica outcome predicted early by ultrasound 178
Incidental findings of anti-mitochondrial antibodies without evidence of Primary Biliary Cholangitis. 177
Dosage and characterization of circulating DNA: present usage and possible applications in systemic autoimmune disorders 174
HLA class II alleles associations of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with SLE 171
Combination therapy with cyclosporine A and anti-TNF-alpha agents in the treatment of rheumatoid arthritis and concomitant hepatitis C virus infection 168
Spontaneous chromosome damage (micronuclei) in systemic sclerosis and Raynaud's phenomenon 167
Evaluation of the effect of Bosentan treatment on proinflammatory cytokine serum levels in patients affected by Systemic Sclerosis 161
Low muscle mass and body composition analysis in a group of postmenopausal women affected by primary Sjögren’s syndrome 160
Anti-dense fine speckled 70 antibodies in primary Sjögren's syndrome 160
Efficacy and safety of anti-TNF-alpha therapy combined with cyclosporine A in patients with rheumatoid arthritis and concomitant hepatitis C virus infection 159
Simultaneouspulmonary involvement, histologically proven, of sarcoidosis and rheumatoidarthritis. 157
Associazione interferon α2b e ciclosporina A nel trattamento dell'epatite cronica C: Trial controllato 157
Interstitial lung disease associated with psoriatic arthritis: a new disease entity? 156
Pleuroparenchymal fibroelastosis in patients affected by systemic sclerosis: What should the rheumatologist do? 151
Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicenter prospective study of 1000 patients. 150
The Role of Multimodality Imaging in Monitoring Disease Activity and Therapeutic Response to Tocilizumab in Giant Cell Arteritis 146
La tipizzazione genetica nelle malattie reumatiche autoimmuni e nelle sindromi autoinflammatorie 132
Le indicazioni al trattamento con immunoglobuline endovena nella sindrome da anticorpi antifosfolipidi. [Indications for intra-venous immunoglobulins treatment in the antiphospholipid syndrome] 127
Real-Life Data on the Efficacy of Canakinumab in Patients with Adult-Onset Still's Disease 117
Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients. 101
null 99
Krebs von den Lungen-6 as biomarker of the new progressive fibrotic phenotype of interstitial lung disease 92
Totale 12.855
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.813
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.813
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022687 48 78 44 77 27 16 30 20 30 65 88 164
2022/20231.061 67 105 151 147 104 211 16 87 104 22 28 19
2023/2024838 36 16 77 78 28 230 279 9 3 10 11 61
2024/20251.725 35 89 203 81 225 93 65 87 124 80 215 428
2025/20264.868 333 607 756 558 1.050 241 476 88 129 211 80 339
2026/202757 57 0 0 0 0 0 0 0 0 0 0 0
Totale 12.855